1.
Solis-Herrera, C., et al., Pathogenesis of Type 2 Diabetes Mellitus, in Endotext,
K.R. Feingold, et al., Editors. 2000, MDText.com, Inc.Copyright © 2000-2021,
MDText.com, Inc.: South Dartmouth (MA).
2.
Jin, Q. and R.C.W. Ma, Metabolomics in Diabetes and Diabetic Complications:
Insights from Epidemiological Studies. Cells, 2021. 10(11).
3.
Meyhöfer, S. and S.M. Schmid, [Diabetes complications - diabetes and the
nervous system]. Dtsch Med Wochenschr, 2020. 145(22): p. 1599-1605.
4.
Huebschmann, A.G., et al., Sex differences in the burden of type 2 diabetes and
cardiovascular risk across the life course. Diabetologia, 2019. 62(10): p. 17611772.
5.
Lake, A.J., A. Bo, and M. Hadjiconstantinou, Developing and Evaluating
Behaviour Change Interventions for People with Younger-Onset Type 2
Diabetes: Lessons and Recommendations from Existing Programmes. Curr
Diab Rep, 2021. 21(12): p. 59.
6.
Andersson, C. and R.S. Vasan, Epidemiology of cardiovascular disease in young
individuals. Nat Rev Cardiol, 2018. 15(4): p. 230-240.
7.
Henning, R.J., Type-2 diabetes mellitus and cardiovascular disease. Future
Cardiol, 2018. 14(6): p. 491-509.
8.
Martín-Peláez, S., M. Fito, and O. Castaner, Mediterranean Diet Effects on Type
2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A
Review. Nutrients, 2020. 12(8).
9.
Laakso, M., Biomarkers for type 2 diabetes. Mol Metab, 2019. 27s(Suppl): p.
S139-s146.
10.
Kanaley, J.A., et al., Exercise/Physical Activity in Individuals with Type 2
Diabetes: A Consensus Statement from the American College of Sports
Medicine. Med Sci Sports Exerc, 2022. 54(2): p. 353-368.
11.
Guess, N.D., Dietary Interventions for the Prevention of Type 2 Diabetes in
High-Risk Groups: Current State of Evidence and Future Research Needs.
81
Nutrients, 2018. 10(9).
12.
Vlachos, D., et al., Glycemic Index (GI) or Glycemic Load (GL) and Dietary
Interventions for Optimizing Postprandial Hyperglycemia in Patients with T2
Diabetes: A Review. Nutrients, 2020. 12(6).
13.
Salamone, D., A.A. Rivellese, and C. Vetrani, The relationship between gut
microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role
of dietary fibre. Acta Diabetol, 2021. 58(9): p. 1131-1138.
14.
Saji, N., et al., The Association between Cerebral Small Vessel Disease and the
Gut Microbiome: A Cross-Sectional Analysis. J Stroke Cerebrovasc Dis, 2021.
30(3): p. 105568.
15.
Arora, A., et al., Unravelling the involvement of gut microbiota in type 2
diabetes mellitus. Life Sci, 2021. 273: p. 119311.
16.
Moszak, M., M. Szulińska, and P. Bogdański, You Are What You Eat-The
Relationship between Diet, Microbiota, and Metabolic Disorders-A Review.
Nutrients, 2020. 12(4).
17.
Crovesy, L., T. El-Bacha, and E.L. Rosado, Modulation of the gut microbiota
by probiotics and symbiotics is associated with changes in serum metabolite
profile related to a decrease in inflammation and overall benefits to metabolic
health: a double-blind randomized controlled clinical trial in women with
obesity. Food Funct, 2021. 12(5): p. 2161-2170.
18.
Yoon, H.S., et al., Akkermansia muciniphila secretes a glucagon-like peptide-1inducing protein that improves glucose homeostasis and ameliorates metabolic
disease in mice. Nat Microbiol, 2021. 6(5): p. 563-573.
19.
Motiani, K.K., et al., Exercise Training Modulates Gut Microbiota Profile and
Improves Endotoxemia. Med Sci Sports Exerc, 2020. 52(1): p. 94-104.
20.
Aragón-Vela, J., et al., Impact of Exercise on Gut Microbiota in Obesity.
Nutrients, 2021. 13(11).
21.
Allen, J.M., et al., Exercise Alters Gut Microbiota Composition and Function in
Lean and Obese Humans. Med Sci Sports Exerc, 2018. 50(4): p. 747-757.
22.
Benson, A.K., et al., Individuality in gut microbiota composition is a complex
82
polygenic trait shaped by multiple environmental and host genetic factors. Proc
Natl Acad Sci U S A, 2010. 107(44): p. 18933-8.
23.
Xu, J., et al., Renalase is a novel, soluble monoamine oxidase that regulates
cardiac function and blood pressure. J Clin Invest, 2005. 115(5): p. 1275-80.
24.
Gao, Y., et al., Renalase is a novel tissue and serological biomarker in pancreatic
ductal adenocarcinoma. PLoS One, 2021. 16(9): p. e0250539.
25.
Guo, X., et al., Inhibition of renalase drives tumour rejection by promoting T
cell activation. Eur J Cancer, 2022. 165: p. 81-96.
26.
Wang, F., et al., Renalase might be associated with hypertension and insulin
resistance in Type 2 diabetes. Ren Fail, 2014. 36(4): p. 552-6.
27.
Buraczynska, M., et al., Renalase gene Glu37Asp polymorphism affects
susceptibility to diabetic retinopathy in type 2 diabetes mellitus. Acta Diabetol,
2021. 58(12): p. 1595-1602.
28.
Buse, J.B., et al., 2019 Update to: Management of Hyperglycemia in Type 2
Diabetes, 2018. A Consensus Report by the American Diabetes Association
(ADA) and the European Association for the Study of Diabetes (EASD).
Diabetes Care, 2020. 43(2): p. 487-493.
29.
Taylor, S.I., Z.S. Yazdi, and A.L. Beitelshees, Pharmacological treatment of
hyperglycemia in type 2 diabetes. J Clin Invest, 2021. 131(2).
30.
Gandhi, G.Y. and A.D. Mooradian, Management of Hyperglycemia in Older
Adults with Type 2 Diabetes. Drugs Aging, 2022. 39(1): p. 39-58.
31.
Ceriello, A., et al., Glycaemic management in diabetes: old and new approaches.
Lancet Diabetes Endocrinol, 2022. 10(1): p. 75-84.
32.
Piché, M.E., A. Tchernof, and J.P. Després, Obesity Phenotypes, Diabetes, and
Cardiovascular Diseases. Circ Res, 2020. 126(11): p. 1477-1500.
33.
Greenwood, M., et al., Transcription factor Creb3l1 regulates the synthesis of
prohormone convertase enzyme PC1/3 in endocrine cells. J Neuroendocrinol,
2020. 32(4): p. e12851.
34.
Lafferty, R.A., et al., Proglucagon-Derived Peptides as Therapeutics. Front
Endocrinol (Lausanne), 2021. 12: p. 689678.
83
35.
Ramzy, A. and T.J. Kieffer, Altered islet prohormone processing: a cause or
consequence of diabetes? Physiol Rev, 2022. 102(1): p. 155-208.
36.
Saeedi, P., et al., Global and regional diabetes prevalence estimates for 2019 and
projections for 2030 and 2045: Results from the International Diabetes
Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract, 2019. 157: p.
107843.
37.
Okamura, T., et al., Ectopic fat obesity presents the greatest risk for incident
type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond), 2019.
43(1): p. 139-148.
38.
Wu, H. and C.M. Ballantyne, Metabolic Inflammation and Insulin Resistance
in Obesity. Circ Res, 2020. 126(11): p. 1549-1564.
39.
Ahmed, B., R. Sultana, and M.W. Greene, Adipose tissue and insulin resistance
in obese. Biomed Pharmacother, 2021. 137: p. 111315.
40.
Zatterale, F., et al., Chronic Adipose Tissue Inflammation Linking Obesity to
Insulin Resistance and Type 2 Diabetes. Front Physiol, 2019. 10: p. 1607.
41.
Huang, X., et al., The PI3K/AKT pathway in obesity and type 2 diabetes. Int J
Biol Sci, 2018. 14(11): p. 1483-1496.
42.
Chen, Q., et al., JNK/PI3K/Akt signaling pathway is involved in myocardial
ischemia/reperfusion injury in diabetic rats: effects of salvianolic acid A
intervention. Am J Transl Res, 2016. 8(6): p. 2534-48.
43.
Fatima, S.S., et al., Polymorphism of the renalase gene in gestational diabetes
mellitus. Endocrine, 2017. 55(1): p. 124-129.
44.
Teimoori, B., et al., Renalase rs10887800 polymorphism is associated with
severe pre-eclampsia in southeast Iranian women. J Cell Biochem, 2019.
120(3): p. 3277-3285.
45.
Zhang, F., et al., Association of renalase gene polymorphisms with the risk of
hypertensive disorders of pregnancy in northeastern Han Chinese population.
Gynecol Endocrinol, 2020. 36(11): p. 986-990.
46.
Tokinoya, K., et al., Influence of acute exercise on renalase and its regulatory
mechanism. Life Sci, 2018. 210: p. 235-242.
84
47.
Tokinoya, K., et al., Gene expression level of renalase in the skeletal muscles is
increased with high-intensity exercise training in mice on a high-fat diet.
Physiol Int, 2021.
48.
Tokinoya, K., et al., Moderate-intensity exercise increases renalase levels in the
blood and skeletal muscle of rats. FEBS Open Bio, 2020. 10(6): p. 1005-1012.
49.
Czarkowska-Paczek, B., et al., Exercise differentially regulates renalase
expression in skeletal muscle and kidney. Tohoku J Exp Med, 2013. 231(4): p.
321-9.
50.
Luo, M., et al., Aerobic Exercise Training Improves Renal Injury in
Spontaneously Hypertensive Rats by Increasing Renalase Expression in
Medulla. Front Cardiovasc Med, 2022. 9: p. 922705.
51.
Aoki, K., et al., Renalase is localized to the small intestine crypt and expressed
upon the activation of NF-κB p65 in mice model of fasting-induced oxidative
stress. Life Sci, 2021. 267: p. 118904.
52.
Pointer, T.C., F.S. Gorelick, and G.V. Desir, Renalase: A Multi-Functional
Signaling Molecule with Roles in Gastrointestinal Disease. Cells, 2021. 10(8).
53.
Czerwińska, K., R. Poręba, and P. Gać, Renalase-A new understanding of its
enzymatic and non-enzymatic activity and its implications for future research.
Clin Exp Pharmacol Physiol, 2022. 49(1): p. 3-9.
54.
Mitsuoka, T., Intestinal flora and aging. Nutr Rev, 1992. 50(12): p. 438-46.
55.
Ibal, J.C., et al., Review of the Current State of Freely Accessible Web Tools for
the Analysis of 16S rRNA Sequencing of the Gut Microbiome. Int J Mol Sci,
2022. 23(18).
56.
Gao, B., et al., An Introduction to Next Generation Sequencing Bioinformatic
Analysis in Gut Microbiome Studies. Biomolecules, 2021. 11(4).
57.
Abellan-Schneyder, I., et al., Primer, Pipelines, Parameters: Issues in 16S rRNA
Gene Sequencing. mSphere, 2021. 6(1).
58.
Korostin, D., et al., Comparative analysis of novel MGISEQ-2000 sequencing
platform vs Illumina HiSeq 2500 for whole-genome sequencing. PLoS One,
2020. 15(3): p. e0230301.
85
59.
Nguyen, N.P., et al., A perspective on 16S rRNA operational taxonomic unit
clustering using sequence similarity. NPJ Biofilms Microbiomes, 2016. 2: p.
16004.
60.
<ijs-44-4-846.pdf>.
61.
Hall, M. and R.G. Beiko, 16S rRNA Gene Analysis with QIIME2. Methods Mol
Biol, 2018. 1849: p. 113-129.
62.
Poos, M.S., S.C. Walker, and D.A. Jackson, Functional-diversity indices can be
driven by methodological choices and species richness. Ecology, 2009. 90(2):
p. 341-7.
63.
Ramette, A., Multivariate analyses in microbial ecology. FEMS Microbiol Ecol,
2007. 62(2): p. 142-60.
64.
Mori, A.S., F. Isbell, and R. Seidl, β-Diversity, Community Assembly, and
Ecosystem Functioning. Trends Ecol Evol, 2018. 33(7): p. 549-564.
65.
Lozupone, C.A., et al., Quantitative and qualitative beta diversity measures lead
to different insights into factors that structure microbial communities. Appl
Environ Microbiol, 2007. 73(5): p. 1576-85.
66.
Chang, F., S. He, and C. Dang, Assisted Selection of Biomarkers by Linear
Discriminant Analysis Effect Size (LEfSe) in Microbiome Data. J Vis Exp,
2022(183).
67.
Thingholm, L.B., et al., Obese Individuals with and without Type 2 Diabetes
Show Different Gut Microbial Functional Capacity and Composition. Cell Host
Microbe, 2019. 26(2): p. 252-264.e10.
68.
Turnbaugh, P.J., et al., A core gut microbiome in obese and lean twins. Nature,
2009. 457(7228): p. 480-4.
69.
Gurung, M., et al., Role of gut microbiota in type 2 diabetes pathophysiology.
EBioMedicine, 2020. 51: p. 102590.
70.
Han, J.L. and H.L. Lin, Intestinal microbiota and type 2 diabetes: from
mechanism insights to therapeutic perspective. World J Gastroenterol, 2014.
20(47): p. 17737-45.
71.
Qin, J., et al., A metagenome-wide association study of gut microbiota in type
86
2 diabetes. Nature, 2012. 490(7418): p. 55-60.
72.
Zhao, J., et al., Dietary Fiber Increases Butyrate-Producing Bacteria and
Improves the Growth Performance of Weaned Piglets. J Agric Food Chem, 2018.
66(30): p. 7995-8004.
73.
Couto, M.R., et al., Microbiota-derived butyrate regulates intestinal
inflammation: Focus on inflammatory bowel disease. Pharmacol Res, 2020.
159: p. 104947.
74.
Mohammadi, S.O., et al., The impact of Helicobacter pylori infection on gut
microbiota-endocrine system axis; modulation of metabolic hormone levels and
energy homeostasis. J Diabetes Metab Disord, 2020. 19(2): p. 1855-1861.
75.
Tanase, D.M., et al., Role of Gut Microbiota on Onset and Progression of
Microvascular Complications of Type 2 Diabetes (T2DM). Nutrients, 2020.
12(12).
76.
Wang, P.X., et al., Gut microbiota and metabolic syndrome. Chin Med J (Engl),
2020. 133(7): p. 808-816.
77.
Everard, A., et al., Responses of gut microbiota and glucose and lipid
metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.
Diabetes, 2011. 60(11): p. 2775-86.
78.
Wang, Y., et al., Composite probiotics alleviate type 2 diabetes by regulating
intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomed
Pharmacother, 2020. 125: p. 109914.
79.
Kaji, I., S. Karaki, and A. Kuwahara, Short-chain fatty acid receptor and its
contribution to glucagon-like peptide-1 release. Digestion, 2014. 89(1): p. 31-6.
80.
Tazoe, H., et al., Roles of short-chain fatty acids receptors, GPR41 and GPR43
on colonic functions. J Physiol Pharmacol, 2008. 59 Suppl 2: p. 251-62.
81.
Benítez-Páez, A., et al., Sex, Food, and the Gut Microbiota: Disparate Response
to Caloric Restriction Diet with Fiber Supplementation in Women and Men. Mol
Nutr Food Res, 2021. 65(8): p. e2000996.
82.
Barton, W., et al., The microbiome of professional athletes differs from that of
more sedentary subjects in composition and particularly at the functional
87
metabolic level. Gut, 2018. 67(4): p. 625-633.
83.
McCabe, L.R., et al., Exercise prevents high fat diet-induced bone loss, marrow
adiposity and dysbiosis in male mice. Bone, 2019. 118: p. 20-31.
84.
Aoki, T., et al., The Effect of Voluntary Exercise on Gut Microbiota in Partially
Hydrolyzed Guar Gum Intake Mice under High-Fat Diet Feeding. Nutrients,
2020. 12(9).
85.
Kulecka, M., et al., The composition and richness of the gut microbiota
differentiate the top Polish endurance athletes from sedentary controls. Gut
Microbes, 2020. 11(5): p. 1374-1384.
86.
Lahiri, S., et al., The gut microbiota influences skeletal muscle mass and
function in mice. Sci Transl Med, 2019. 11(502).
87.
Domínguez-Balmaseda, D. and G. García-Pérez-de-Sevilla, The Relationship
between the Gut Microbiota and Exercise: A Narrative Review. Hygiene, 2022.
2(4): p. 152-162.
88.
Kumar, J., K. Rani, and C. Datt, Molecular link between dietary fibre, gut
microbiota and health. Mol Biol Rep, 2020. 47(8): p. 6229-6237.
89.
Wang, K., et al., Parabacteroides distasonis Alleviates Obesity and Metabolic
Dysfunctions via Production of Succinate and Secondary Bile Acids. Cell Rep,
2019. 26(1): p. 222-235.e5.
90.
Schoeler, M. and R. Caesar, Dietary lipids, gut microbiota and lipid metabolism.
Rev Endocr Metab Disord, 2019. 20(4): p. 461-472.
91.
Larsen, N., et al., Gut microbiota in human adults with type 2 diabetes differs
from non-diabetic adults. PLoS One, 2010. 5(2): p. e9085.
92.
Lê, K.A., et al., Alterations in fecal Lactobacillus and Bifidobacterium species
in type 2 diabetic patients in Southern China population. Front Physiol, 2012.
3: p. 496.
93.
Suzuki, T.A. and R.E. Ley, The role of the microbiota in human genetic
adaptation. Science, 2020. 370(6521).
94.
Goodrich, J.K., et al., The Relationship Between the Human Genome and
Microbiome Comes into View. Annu Rev Genet, 2017. 51: p. 413-433.
88
95.
Liu, X., et al., Metagenome-genome-wide association studies reveal human
genetic impact on the oral microbiome. Cell Discov, 2021. 7(1): p. 117.
96.
de Moura, E.D.M., et al., Diet-induced obesity in animal models: points to
consider and influence on metabolic markers. Diabetol Metab Syndr, 2021.
13(1): p. 32.
97.
Kleinert, M., et al., Animal models of obesity and diabetes mellitus. Nat Rev
Endocrinol, 2018. 14(3): p. 140-162.
98.
King, A.J., The use of animal models in diabetes research. Br J Pharmacol, 2012.
166(3): p. 877-94.
99.
<56_263.pdf>.
100. Fraulob, J.C., et al., A Mouse Model of Metabolic Syndrome: Insulin Resistance,
Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6
Mice Fed a High Fat Diet. J Clin Biochem Nutr, 2010. 46(3): p. 212-23.
101.
Heydemann, A., An Overview of Murine High Fat Diet as a Model for Type 2
Diabetes Mellitus. J Diabetes Res, 2016. 2016: p. 2902351.
102.
Kleinert, M., et al., Animal models of obesity and diabetes mellitus. Nat Rev
Endocrinol, 2018. 14(3): p. 140-162.
103.
Tokinoya, K., et al., Denervation-induced muscle atrophy suppression in
renalase-deficient mice via increased protein synthesis. Physiol Rep, 2020.
8(15): p. e14475.
104.
Tokinoya, K., et al., Effects of renalase deficiency on liver fibrosis markers in a
nonalcoholic steatohepatitis mouse model. Mol Med Rep, 2021. 23(3).
105.
Islam, M.R., et al., Weight Gain, Glucose Tolerance, and the Gut Microbiome
of Male C57BL/6J Mice Housed on Corncob or Paper Bedding and Fed Normal
or High-Fat Diet. J Am Assoc Lab Anim Sci, 2021. 60(4): p. 407-421.
106.
Liang, H., et al., A high-fat diet and high-fat and high-cholesterol diet may affect
glucose and lipid metabolism differentially through gut microbiota in mice. Exp
Anim, 2021. 70(1): p. 73-83.
107.
Chacko, E., Blunting post-meal glucose surges in people with diabetes. World J
Diabetes, 2016. 7(11): p. 239-42.
89
108.
Lin, X.J., H.F. Yang, and X.H. Wang, [Effects of aerobic exercise and dieting
on chemerin and its receptor CMKLR1 in the livers of type 2 diabetic rats].
Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2017. 33(5): p. 426-430.
109.
McDonald, S.M., et al., The effects of aerobic exercise on markers of maternal
metabolism during pregnancy. Birth Defects Res, 2021. 113(3): p. 227-237.
110.
Zhou, Y., et al., Benefits of different combinations of aerobic and resistance
exercise for improving plasma glucose and lipid metabolism and sleep quality
among elderly patients with metabolic syndrome: a randomized controlled trial.
Endocr J, 2022. 69(7): p. 819-830.
111.
Emami, S.R., et al., Impact of eight weeks endurance training on biochemical
parameters and obesity-induced oxidative stress in high fat diet-fed rats. J Exerc
Nutrition Biochem, 2016. 20(1): p. 29-35.
112.
Vogt É, L., et al., Metabolic and Molecular Subacute Effects of a Single
Moderate-Intensity Exercise Bout, Performed in the Fasted State, in Obese Male
Rats. Int J Environ Res Public Health, 2021. 18(14).
113.
Beck, D. and J.A. Foster, Machine learning techniques accurately classify
microbial communities by bacterial vaginosis characteristics. PLoS One, 2014.
9(2): p. e87830.
114.
Yatsunenko, T., et al., Human gut microbiome viewed across age and geography.
Nature, 2012. 486(7402): p. 222-7.
115.
Kaul, A., O. Davidov, and S.D. Peddada, Structural zeros in high-dimensional
data with applications to microbiome studies. Biostatistics, 2017. 18(3): p. 422433.
116.
Yu, D., et al., Profiling of gut microbial dysbiosis in adults with myeloid
leukemia. FEBS Open Bio, 2021. 11(7): p. 2050-2059.
117.
Liu, X., et al., A genome-wide association study for gut metagenome in Chinese
adults illuminates complex diseases. Cell Discov, 2021. 7(1): p. 9.
118.
Zhao, L., et al., A combination of quercetin and resveratrol reduces obesity in
high-fat diet-fed rats by modulation of gut microbiota. Food Funct, 2017. 8(12):
p. 4644-4656.
90
119.
Lu, L., et al., Gut Microbiota and Serum Metabolic Signatures of High-FatInduced Bone Loss in Mice. Front Cell Infect Microbiol, 2021. 11: p. 788576.
120.
Yang, B., et al., Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic
Syndrome in Mice via Gut Microbiota Modulation and Alleviating
Inflammation. Foods, 2021. 10(9).
121.
Zhang, C., et al., Lactobacillus reuteri J1 prevents obesity by altering the gut
microbiota and regulating bile acid metabolism in obese mice. Food Funct, 2022.
13(12): p. 6688-6701.
122.
Xiao, Y., et al., Colonized Niche, Evolution and Function Signatures of
Bifidobacterium pseudolongum within Bifidobacterial Genus. Foods, 2021.
10(10).
123.
Lieber, A.D., et al., Loss of HDAC6 alters gut microbiota and worsens obesity.
Faseb j, 2019. 33(1): p. 1098-1109.
124.
Yuan, G., M. Tan, and X. Chen, Punicic acid ameliorates obesity and liver
steatosis by regulating gut microbiota composition in mice. Food Funct, 2021.
12(17): p. 7897-7908.
125.
Zhang, X., et al., Dietary cholesterol drives fatty liver-associated liver cancer
by modulating gut microbiota and metabolites. Gut, 2021. 70(4): p. 761-774.
126.
Hu, Y., et al., Pleurotus Ostreatus Ameliorates Obesity by Modulating the Gut
Microbiota in Obese Mice Induced by High-Fat Diet. Nutrients, 2022. 14(9).
127.
Singh, P., et al., High FODMAP diet causes barrier loss via lipopolysaccharidemediated mast cell activation. JCI Insight, 2021. 6(22).
128.
Meelu, P., et al., Impaired innate immune function associated with fecal
supernatant from Crohn's disease patients: insights into potential pathogenic
role of the microbiome. Inflamm Bowel Dis, 2014. 20(7): p. 1139-46.
129.
Azaryan, A.V., T.J. Krieger, and V.Y. Hook, Purification and characteristics of
the candidate prohormone processing proteases PC2 and PC1/3 from bovine
adrenal medulla chromaffin granules. J Biol Chem, 1995. 270(14): p. 8201-8.
130.
Magne, F., et al., The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut
Dysbiosis in Obese Patients? Nutrients, 2020. 12(5).
91
131.
Bo, T.B., et al., Bifidobacterium pseudolongum reduces triglycerides by
modulating gut microbiota in mice fed high-fat food. J Steroid Biochem Mol
Biol, 2020. 198: p. 105602.
132.
Zhang, Q., et al., Influenza infection elicits an expansion of gut population of
endogenous Bifidobacterium animalis which protects mice against infection.
Genome Biol, 2020. 21(1): p. 99.
133.
Zhang, H.Y., et al., Therapeutic mechanisms of traditional Chinese medicine to
improve metabolic diseases via the gut microbiota. Biomed Pharmacother, 2021.
133: p. 110857.
134.
Kaska, L., et al., Improved glucose metabolism following bariatric surgery is
associated with increased circulating bile acid concentrations and remodeling
of the gut microbiome. World J Gastroenterol, 2016. 22(39): p. 8698-8719.
135.
Sun, L., et al., Ablation of gut microbiota alleviates obesity-induced hepatic
steatosis and glucose intolerance by modulating bile acid metabolism in
hamsters. Acta Pharm Sin B, 2019. 9(4): p. 702-710.
136.
Tveter, K.M., et al., Polyphenol-induced improvements in glucose metabolism
are associated with bile acid signaling to intestinal farnesoid X receptor. BMJ
Open Diabetes Res Care, 2020. 8(1).
137.
Spor, A., O. Koren, and R. Ley, Unravelling the effects of the environment and
host genotype on the gut microbiome. Nat Rev Microbiol, 2011. 9(4): p. 27990.
138.
De Angelis, M., et al., The Food-gut Human Axis: The Effects of Diet on Gut
Microbiota and Metabolome. Curr Med Chem, 2019. 26(19): p. 3567-3583.
139.
Wang, H., et al., Phyllanthin inhibits MOLT-4 leukemic cancer cell growth and
induces apoptosis through the inhibition of AKT and JNK signaling pathway. J
Biochem Mol Toxicol, 2021. 35(6): p. 1-10.
140.
Zheng, B., et al., Rhoifolin from Plumula Nelumbinis exhibits anti-cancer
effects in pancreatic cancer via AKT/JNK signaling pathways. Sci Rep, 2022.
12(1): p. 5654.
141.
Zhao, L., et al., MicroRNA-4268 inhibits cell proliferation via AKT/JNK
92
signalling pathways by targeting Rab6B in human gastric cancer. Cancer Gene
Ther, 2020. 27(6): p. 461-472.
142.
Wang, L., et al., Renalase prevents AKI independent of amine oxidase activity.
J Am Soc Nephrol, 2014. 25(6): p. 1226-35.
143.
Wu, Y., et al., Renalase improves pressure overload-induced heart failure in rats
by regulating extracellular signal-regulated protein kinase 1/2 signaling.
Hypertens Res, 2021. 44(5): p. 481-488.
144.
Zhang, T., et al., Renalase Attenuates Mouse Fatty Liver Ischemia/Reperfusion
Injury through Mitigating Oxidative Stress and Mitochondrial Damage via
Activating SIRT1. Oxid Med Cell Longev, 2019. 2019: p. 7534285.
145.
Razolli, D.S., et al., Proopiomelanocortin Processing in the Hypothalamus Is
Directly Regulated by Saturated Fat: Implications for the Development of
Obesity. Neuroendocrinology, 2020. 110(1-2): p. 92-104.
146.
Tolhurst, G., et al., Short-chain fatty acids stimulate glucagon-like peptide-1
secretion via the G-protein-coupled receptor FFAR2. Diabetes, 2012. 61(2): p.
364-71.
147.
Scott, K.P., et al., The influence of diet on the gut microbiota. Pharmacol Res,
2013. 69(1): p. 52-60.
148.
Charrier, J.A., et al., High fat diet partially attenuates fermentation responses in
rats fed resistant starch from high-amylose maize. Obesity (Silver Spring), 2013.
21(11): p. 2350-5.
149.
Hoshino, A., et al., Modulation of PC1/3 activity by self-interaction and
substrate binding. Endocrinology, 2011. 152(4): p. 1402-11.
150.
Barnard, R.J., et al., Effects of a high-fat, sucrose diet on serum insulin and
related atherosclerotic risk factors in rats. Atherosclerosis, 1993. 100(2): p. 22936.
151.
Barnard, R.J., et al., Diet-induced insulin resistance precedes other aspects of
the metabolic syndrome. J Appl Physiol (1985), 1998. 84(4): p. 1311-5.
152. Bilu, C., et al., Beneficial effects of voluntary wheel running on activity rhythms,
metabolic state, and affect in a diurnal model of circadian disruption. Sci Rep,
93
2022. 12(1): p. 2434.
153.
Tanaka, Y., et al., Effect of a single bout of morning or afternoon exercise on
glucose fluctuation in young healthy men. Physiol Rep, 2021. 9(7): p. e14784.
154.
Wang, H., et al., Effects of Different Intensity Exercise on Glucose Metabolism
and Hepatic IRS/PI3K/AKT Pathway in SD Rats Exposed with TCDD. Int J
Environ Res Public Health, 2021. 18(24).
155.
Lee, S., et al., Effects of long-term exercise on plasma adipokine levels and
inflammation-related gene expression in subcutaneous adipose tissue in
sedentary dysglycaemic, overweight men and sedentary normoglycaemic men
of healthy weight. Diabetologia, 2019. 62(6): p. 1048-1064.
156.
Younossi, Z.M., K.E. Corey, and J.K. Lim, AGA Clinical Practice Update on
Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the
Management of Nonalcoholic Fatty Liver Disease: Expert Review.
Gastroenterology, 2021. 160(3): p. 912-918.
157.
Ahmed, S. and J.D. Spence, Sex differences in the intestinal microbiome:
interactions with risk factors for atherosclerosis and cardiovascular disease. Biol
Sex Differ, 2021. 12(1): p. 35.
94
...
論文の公開元へ
